무혈성 괴사 시장 규모, 점유율, 성장 분석 : 치료법별, 병기별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Avascular Necrosis Market size was valued at USD 4852.50 Million in 2024 and is poised to grow from USD 5193.15 Million in 2025 to USD 8985.40 Million by 2033, growing at a CAGR of 7.02% during the forecast period (2026-2033).

The global avascular necrosis (AVN) market is primarily driven by the increasing prevalence of osteonecrosis in older populations and steroid users, who typically present with multiple health issues that exacerbate joint deterioration. This market encompasses diagnostics, surgical, pharmaceutical treatments, and rehabilitation strategies. Effective treatment is critical, as untreated AVN can lead to joint collapse, imposing significant financial and quality of life burdens. Recent trends highlight a shift from symptom management to early imaging techniques that focus on joint preservation, exemplified by MRI advancements and combined procedures like core decompression with biologics. The integration of technology facilitates early detection of asymptomatic cases, amplifying the demand for joint-preserving interventions. Additionally, enhancements in minimally invasive surgeries and expanded reimbursement models will broaden patient access to care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Avascular Necrosis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Avascular Necrosis Market Segments Analysis

Global avascular necrosis market is segmented by treatment type, stage, end-user and region. Based on treatment type, the market is segmented into surgical and non-surgical. Based on stage, the market is segmented into early stage (I-II) and late stage (III-IV). Based on end-user, the market is segmented into hospitals, orthopedic clinics and rehabilitation centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Avascular Necrosis Market

The expansion of the global avascular necrosis market is significantly influenced by advancements in surgical techniques, which have improved patient outcomes and enhanced clinician confidence in treating this condition. With the increasing predictability of surgical approaches, more healthcare facilities are adopting these procedures and investing in necessary equipment and staff training. As surgeons refine minimally invasive and joint-preserving techniques, the trend toward earlier surgical intervention is likely to evolve referral patterns, leading to heightened demand for implants and regenerative materials. This shift fosters integrated care pathways, promoting wider acceptance and growth within the market.

Restraints in the Global Avascular Necrosis Market

The Global Avascular Necrosis market faces significant challenges due to the high costs associated with advanced surgical procedures and implantable devices, which may impede the adoption of innovative technologies. Healthcare payers and systems often prioritize cost containment, leading to restricted reimbursements for new technologies and a preference for established solutions that already demonstrate success. This focus creates a disincentive to embrace novel advancements, despite available clinical evidence supporting their efficacy. Additionally, the financial burden on patients and hospitals related to out-of-pocket expenses and the necessary investment in training and equipment presents further obstacles to integrating new therapies into standard care practices, thereby limiting market growth.

Market Trends of the Global Avascular Necrosis Market

The global market for Avascular Necrosis (AVN) is witnessing a transformative trend towards biologics and regenerative therapies, driven by a shift in clinical focus towards preserving joint function and enhancing patient quality of life. The emergence of bioengineered implants, growth factor applications, and scaffolding materials underscores a concerted effort among researchers and clinicians to develop innovative treatments that promote bone healing and reduce the need for invasive surgeries. Collaboration between orthopedic and biotechnology firms is fostering a surge in clinical research and product development, while healthcare providers increasingly prioritize long-term outcomes, signaling a growing acceptance of biologic solutions in the management of AVN.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Avascular Necrosis Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Surgical
  • Medications (NSAIDs, Bisphosphonates)
  • Physical Therapy
  • Electrical Stimulation
• Non-Surgical

Global Avascular Necrosis Market Size by Stage & CAGR (2026-2033)

• Market Overview
• Early Stage (I-II)
• Late Stage (III-IV)

Global Avascular Necrosis Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Orthopedic Clinics
• Rehabilitation Centers

Global Avascular Necrosis Market Size & CAGR (2026-2033)

• North America (Treatment Type, Stage, End-User)
  • US
  • Canada
• Europe (Treatment Type, Stage, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Stage, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Stage, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Stage, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zimmer Biomet
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DePuy Synthes (J&J)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wright Medical Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exactech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Conformis Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merete Medical GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations